Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CDNA

Caredx Inc

May 12 • 02:59PM ET

21.45

-0.09 -0.44 %

Healthcare • Diagnostics & Research • USA • Small • NASD

May 11, 4:11 PMCareDx 2021 qui tam lawsuit dismissed with no monetary payment required

Peers: NTRA GH MYGN PSNL NEO

| Held by: ARKG XBI VTI IWM VXF IWO PBE IBB SCHA JSMD

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.15	Insider Own	10.76%	Shs Outstand	51.27M	Perf Week	3.65%
Market Cap	1.11B	Forward P/E	18.92	EPS next Y	1.13	Insider Trans	-0.97%	Shs Float	46.10M	Perf Month	27.48%
Enterprise Value	945.67M	PEG	0.50	EPS next Q	0.23	Inst Own	95.19%	Short Float	14.95%	Perf Quarter	4.30%
Income	-8.19M	P/S	2.68	EPS this Y	61.03%	Inst Trans	-4.23%	Short Ratio	9.97	Perf Half Y	37.36%
Sales	412.82M	P/B	3.51	EPS next Y	21.41%	ROA	-1.82%	Short Interest	6.89M	Perf YTD	13.88%
Book/sh	6.11	P/C	5.92	EPS next 5Y	38.17%	ROE	-2.36%	52W High	23.24 -7.68%	Perf Year	31.14%
Cash/sh	3.62	P/FCF	17.09	EPS past 3/5Y	34.67% 0.09%	ROIC	-2.47%	52W Low	10.96 95.76%	Perf 3Y	166.52%
Dividend Est.	-	EV/EBITDA	125.25	Sales past 3/5Y	5.68% 14.59%	Gross Margin	68.25%	Volatility	4.70% 7.38%	Perf 5Y	-65.96%
Dividend TTM	-	EV/Sales	2.29	EPS Y/Y TTM	-111.99%	Oper. Margin	-3.11%	ATR (14)	1.33	Perf 10Y	407.21%
Dividend Ex-Date	-	Quick Ratio	3.07	Sales Y/Y TTM	19.17%	Profit Margin	-1.98%	RSI (14)	58.07	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	3.40	EPS Q/Q	128.24%	SMA20	1.90%	Beta	2.49	Target Price	25.80
Payout	-	Debt/Eq	0.08	Sales Q/Q	38.99%	SMA50	13.37%	Rel Volume	0.37	Prev Close	21.55
Employees	765	LT Debt/Eq	0.06	Earnings	Apr 28 AMC	SMA200	25.68%	Avg Volume	691.38K	Price	21.45
IPO	Jul 17, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	154.68% 15.36%	Trades		Volume	215,240	Change	-0.44%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-26	Downgrade	Craig Hallum	Buy → Hold	$26
Aug-26-25	Initiated	William Blair	Mkt Perform
Jan-15-25	Upgrade	Wells Fargo	Underweight → Equal Weight	$28 → $24
Aug-28-24	Initiated	Wells Fargo	Underweight	$28
Aug-19-24	Upgrade	BTIG Research	Neutral → Buy	$40
May-13-24	Downgrade	Raymond James	Outperform → Mkt Perform
May-01-24	Upgrade	Craig Hallum	Hold → Buy	$15
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight	$10
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform	$12
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight	$19 → $9
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold	$26 → $9
Apr-25-22	Initiated	Stephens	Overweight	$50
Jul-20-21	Resumed	BTIG Research	Buy	$115
Jun-03-21	Initiated	Goldman	Buy	$95
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy	$47 → $55
Oct-08-20	Reiterated	H.C. Wainwright	Buy	$45 → $47
Oct-02-20	Reiterated	H.C. Wainwright	Buy	$40 → $45

Show Previous Ratings

May-11-26 04:05PM	CareDx Announces Dismissal of 2021 Qui Tam Suit (Business Wire)
May-01-26 04:01PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-29-26 08:30AM	CareDx, Inc Q1 2026 Earnings Call Summary (Moby) -5.07%
03:10AM	CareDx Inc (CDNA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com)
Apr-28-26 08:41PM	CareDx to Acquire Naveris to Expand Into Cancer MRD Testing (Exec Edge)
04:18PM	Loading…
04:18PM	CareDx: Q1 Earnings Snapshot (Associated Press)
04:05PM	CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing (Business Wire)
04:01PM	CareDx Announces First Quarter 2026 Financial Results (Business Wire)
Apr-21-26 04:01PM	CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual Meeting (Business Wire)
Apr-20-26 07:05AM	CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing (Business Wire)
Apr-16-26 09:49AM	Why Diagnostics Names CareDx And QuidelOrtho Just Diverged (Investor's Business Daily) +27.60%
Apr-15-26 04:30PM	CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results (Business Wire)
Apr-14-26 04:01PM	CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 (Business Wire)
Mar-07-26 05:02PM	CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference (MarketBeat)
Mar-05-26 04:01PM	CareDx Announces VANTx, an AIPowered Clinical Data & Analytics Platform Built on CareDxs Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets (Business Wire)
04:01PM	Loading…
Feb-27-26 04:01PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-25-26 08:02PM	CareDx, Inc Q4 2025 Earnings Call Summary (Moby)
12:04AM	CareDx Inc (CDNA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com)
Feb-24-26 11:11PM	CareDx Q4 Earnings Call Highlights (MarketBeat)
08:00PM	CareDx (CDNA) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:30PM	CareDx (CDNA) Q4 Earnings Miss Estimates (Zacks)
05:15PM	CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer (Business Wire)
04:21PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	CareDx Announces Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-18-26 08:00AM	CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference (Business Wire)
Feb-16-26 11:32AM	CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT (Zacks)
Feb-13-26 01:09AM	CareDx Expands Transplant Plus Into Cell Therapy, Showcases AlloHeme AML/MDS Relapse Data (MarketBeat)
Feb-12-26 07:05AM	CareDx Announces Clinical Validation Results for AlloHeme, the First AI-Powered NGS Surveillance Solution for AML and MDS Post-Cell Therapy (Business Wire)
Feb-10-26 04:01PM	CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (Business Wire)
Feb-03-26 07:05AM	CareDx to Present AlloHeme Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings (Business Wire)
04:05PM	Loading…
Jan-27-26 04:05PM	CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Jan-13-26 10:45AM	NTRA & NVDA Partner to Improve AI Models for Precision Medicine (Zacks)
08:30AM	Implied Volatility Surging for CareDx Stock Options (Zacks)
Jan-12-26 08:57AM	RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models (Zacks) +20.08%
07:05AM	CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Jan-07-26 07:05AM	CareDx and 10x Genomics to Launch ImmuneScape Program - A Multiomics Research Platform to Decode Transplant Rejection and Drug Response (Business Wire)
Jan-06-26 10:48AM	Cigna Shares on the Couch: Time to Stay Strong or Walk Away Now? (Zacks) -5.05%
Dec-26-25 04:05PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-23-25 09:15AM	Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run? (Zacks)
Dec-18-25 05:00PM	CareDx Provides Notice of Proposed Derivative Settlement (Business Wire)
Nov-27-25 09:55AM	Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade (Zacks)
Nov-24-25 04:05PM	SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation (Business Wire)
Nov-07-25 04:05PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.91%
Nov-06-25 08:00AM	CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 (Business Wire) -9.20%
Nov-05-25 12:03AM	CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance (GuruFocus.com) +13.84%
Nov-04-25 07:00PM	CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:15PM	CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
05:12PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Announces Third Quarter 2025 Financial Results (Business Wire)
Nov-03-25 07:52AM	CareDx Inc (CDNA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-27-25 07:05AM	CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer (Business Wire)
Oct-23-25 04:05PM	CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure (Business Wire)
Oct-22-25 04:01PM	CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors (Business Wire)
Oct-21-25 08:00AM	CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025 (Business Wire)
Oct-06-25 07:05AM	CareDx Announces New IVD Products and IVDR Certification for AlloSeq Tx and QTYPE at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting (Business Wire)
Sep-02-25 04:01PM	CareDx Issues Comment Letter on Draft LCD Policy (Business Wire) -8.09%
Aug-26-25 01:08PM	CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential (Benzinga)
Aug-22-25 08:30AM	Do Options Traders Know Something About CareDx Stock We Don't? (Zacks)
Aug-21-25 04:01PM	CareDx to Participate in Wells Fargo Healthcare Conference (Business Wire)
Aug-12-25 08:00AM	Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors (Business Wire) +5.86%
Aug-06-25 06:30PM	Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings (Zacks) -7.86%
05:45PM	CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates (Zacks)
04:57PM	CareDx Announces Appointment of Nathan Smith as Chief Financial Officer (Business Wire)
04:43PM	CareDx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	CareDx Announces Second Quarter 2025 Financial Results (Business Wire)
12:56PM	CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation (Business Wire)
Aug-05-25 10:07AM	What To Expect From CareDx Inc (CDNA) Q2 2025 Earnings (GuruFocus.com)
Jul-31-25 04:01PM	CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress (Business Wire)
Jul-23-25 07:05AM	CareDx to Report Second Quarter 2025 Financial Results (Business Wire)
Jul-22-25 07:06AM	CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains? (Zacks)
Jul-18-25 08:00AM	CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection (Business Wire)
Jun-03-25 04:30PM	CareDx Announces Repurchase of 5% of Outstanding Shares (Business Wire) +10.67%
May-13-25 04:01PM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
May-01-25 03:17AM	CareDx Inc (CDNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments (GuruFocus.com) -10.72%
Apr-30-25 08:39PM	CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript (Seeking Alpha) -6.89%
05:50PM	CareDx (CDNA) Tops Q1 Earnings Estimates (Zacks)
04:50PM	CareDx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports First Quarter 2025 Results (Business Wire)
Apr-29-25 07:05AM	CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-24-25 07:05AM	CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-21-25 04:01PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-08-25 07:05AM	CareDx to Report First Quarter 2025 Financial Results (Business Wire)
Apr-04-25 12:40PM	Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock? (Zacks)
Mar-11-25 07:05AM	CareDx Launches Two Expanded Indications for AlloSure Testing Services (Business Wire)
Feb-27-25 02:20AM	CareDx Inc (CDNA) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-26-25 07:00PM	CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:56PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-25-25 10:39AM	CareDx Inc (CDNA) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
07:05AM	CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict (Business Wire)
Feb-20-25 07:05AM	CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients (Business Wire) -5.34%
Feb-13-25 07:05AM	CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies (Business Wire)
Feb-11-25 07:05AM	CareDx to Report Fourth Quarter and Full Year 2024 Financial Results (Business Wire) -8.43%
03:22AM	CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock? (Zacks)
Feb-10-25 02:51PM	Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj (CNBC TV) +11.16%
02:51PM	Final Trades: NRG Energy, MP Materials, CareDx and Applovin (CNBC TV)
Feb-05-25 09:55AM	Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect? (Zacks)
Jan-29-25 09:40AM	Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-28-25 08:19AM	CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results (Insider Monkey)
Jan-24-25 08:35AM	Heres Why CareDx (CDNA) Traded Lower in Q4 (Insider Monkey)

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novack Jeffrey Adam	Secretary and General Counsel	May 05 '26	Sale	20.68	2,688	55,581	113,924	May 06 04:05 PM
JEFFREY NOVACK	Officer	May 05 '26	Proposed Sale	20.96	2,688	56,340		May 05 04:32 PM
Hanna John Walter JR	President and CEO	Apr 16 '26	Sale	21.12	10,282	217,156	676,475	Apr 20 04:53 PM
JOHN HANNA	Director	Apr 16 '26	Proposed Sale	17.57	10,282	180,655		Apr 16 04:12 PM
Goldberg Michael	Director	Mar 31 '26	Option Exercise	3.35	26,500	88,648	183,961	Apr 01 04:10 PM
Novack Jeffrey Adam	Secretary and General Counsel	Feb 03 '26	Sale	20.56	4,441	91,286	125,364	Feb 04 04:22 PM
JEFFREY NOVACK	Officer	Feb 03 '26	Proposed Sale	20.42	4,441	90,685		Feb 03 04:33 PM
Hanna John Walter JR	President and CEO	Jan 22 '26	Sale	21.16	19,280	408,023	597,405	Jan 23 05:58 PM
Hanna John Walter JR	President and CEO	Jan 21 '26	Sale	21.00	200	4,200	616,685	Jan 23 05:58 PM
Hanna John Walter JR	President and CEO	Jan 15 '26	Sale	21.05	10,156	213,804	616,885	Jan 20 05:30 PM
JOHN HANNA	Director	Jan 15 '26	Proposed Sale	20.32	29,636	602,204		Jan 15 04:40 PM
Novack Jeffrey Adam	Secretary and General Counsel	Dec 04 '25	Sale	19.17	7,293	139,804	97,925	Dec 05 04:07 PM
JEFFREY NOVACK	Officer	Dec 04 '25	Proposed Sale	18.85	7,293	137,473		Dec 04 04:39 PM
Novack Jeffrey Adam	Secretary and General Counsel	Nov 07 '25	Sale	15.52	2,688	41,723	105,218	Nov 10 04:14 PM
Jeffrey Adam Novack	Officer	Nov 07 '25	Proposed Sale	15.01	2,688	40,347		Nov 07 04:37 PM
ABHISHEK JAIN	Officer	Nov 05 '25	Proposed Sale	15.77	53,388	842,050		Nov 05 04:21 PM
ABHISHEK JAIN	Officer	Oct 31 '25	Proposed Sale	14.90	9,964	148,464		Oct 31 04:48 PM
Bickerstaff George	Director	Sep 11 '25	Option Exercise	7.96	29,136	231,923	144,266	Sep 12 05:09 PM
Novack Jeffrey Adam	Secretary and General Counsel	Aug 05 '25	Sale	12.79	2,688	34,381	112,930	Aug 07 04:00 PM
Jeffrey Adam Novack	Officer	Aug 05 '25	Proposed Sale	12.60	2,688	33,869		Aug 05 04:27 PM
Maag Peter	Director	Jul 07 '25	Sale	18.58	10,000	185,831	308,846	Jul 10 04:04 PM
Valantine Hannah	Director	Jun 18 '25	Sale	19.16	10,570	202,566	38,994	Jun 23 04:30 PM
Maag Peter	Director	Jun 17 '25	Sale	19.24	10,000	192,420	318,846	Jun 20 04:30 PM
HANNAH VALANTINE	Director	Jun 18 '25	Proposed Sale	19.52	10,570	206,326		Jun 18 04:26 PM
HAGSTROM WILLIAM A	Director	Jun 11 '25	Option Exercise	13.20	19,391	256,052	73,370	Jun 13 05:06 PM
HAGSTROM WILLIAM A	Director	Jun 11 '25	Sale	19.90	19,391	385,918	53,979	Jun 13 05:06 PM
WILLIAM HAGSTROM	Director	Jun 11 '25	Proposed Sale	19.90	19,391	385,918		Jun 11 04:20 PM
HAGSTROM WILLIAM A	Director	May 28 '25	Option Exercise	7.45	30,000	223,441	83,979	May 30 05:57 PM
HAGSTROM WILLIAM A	Director	May 28 '25	Sale	17.45	30,000	523,413	53,979	May 30 05:57 PM
HAGSTROM WILLIAM A	Director	May 28 '25	Proposed Sale	17.63	30,000	528,900		May 28 05:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDNA

Caredx Inc

Upgrade your Finviz experience